Rotavirus infection in Europe: Time for effective prevention?

Pediatric Infectious Disease Journal

Volumn 25, Issue 1 SUPPL., 2006, Pages

  Lepage, Philippe ^a  

^a HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

Author keywords

Epidemiology; Europe; Intussusception; Rotavirus vaccine

Indexed keywords

ROTAVIRUS VACCINE;

CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DEATH; DEVELOPING COUNTRY; DISEASE SEVERITY; ECONOMIC ASPECT; EUROPE; GASTROENTERITIS; HEALTH CARE POLICY; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; INTUSSUSCEPTION; MORBIDITY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; ROTAVIRUS; VACCINATION; VIRAL GASTROENTERITIS; VIRUS INFECTION; ARTICLE; ECONOMICS; INFANT; PRESCHOOL CHILD; VIROLOGY;

CHILD, PRESCHOOL; EUROPE; GASTROENTERITIS; HUMANS; INFANT; ROTAVIRUS INFECTIONS;

EID: 33646596926     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000197619.71659.76     Document Type: Conference Paper

References (7)

1. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis. 2003;9:565-572.
2. Clark HF, Bernstein DI, Dennehy PH, et al. Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants. J Pediatr. 2004;144:184-190.
3. Vesikari T, Karvonen A, Puustinen L, et al. Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants. Pediatr Infect Dis J. 2004;23:937-943.
4. O'Ryan M, Abate H, Breuer T, et al. For the GlaxoSmithKline Rotavirus Vaccine Study Group. The new attenuated human rotavirus vaccine is safe and not associated with intussusception: a randomized, double-blind, placebo-controlled multinational trial. N Engl J Med. In press.
5. Vesikari T, Clark HG, Offit PA, et al. The effect of dose and composition of a pentavalent rotavirus reassortant vaccine (RotaTeq™) upon efficacy and immunogenicity in healthy infants. In: 40th Annual Meeting of the Infectious Disease Society of America (IDSA), October 24-27, 2002, Chicago, IL. Alexandria, VA: Infectious Diseases Society of America; 2002. abstract 35.
6. De Vos B, Vesikari T, Linhares AC, et al. A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis. Pediatr Infect Dis J. 2004;23(suppl):S179-S182.
7. Murphy TV, Gargiullo PM, Massoudi MS, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344:564-572.